Not Tagged
Castle Biosciences
[]
$cstl late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx -scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort study 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6